Ruff Shamim 4
4 · REATA PHARMACEUTICALS INC · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Ruff Shamim
Director
Transactions
- Award
Class A common stock
2023-06-07$93.61/sh+454$42,499→ 5,677 total - Award
Stock Option (right-to-buy)
2023-06-07+2,137→ 2,137 totalExercise: $93.61Exp: 2033-06-07→ Class A common stock (2,137 underlying) - Award
Class A common stock
2023-06-07$93.61/sh+1,682$157,452→ 7,359 total - Award
Stock Option (right-to-buy)
2023-06-07$73.68/sh+576$42,440→ 576 totalExercise: $93.61Exp: 2033-06-07→ Class A common stock (576 underlying)
Footnotes (4)
- [F1]The shares represent Restricted Stock Units (RSUs), which vest on June 5, 2024, subject to continued service through the vesting date.
- [F2]These RSUs were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $42,499.
- [F3]The option vests in 4 equal installments on September 7, 2023, December 7, 2023, March 7, 2024, and June 5, 2024, subject to continued service through each vesting date.
- [F4]This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $42,441.